Journal profile · Medicine-Infectious Diseases
JAMMI
ISSN 2371-0888 · University of Toronto Press
JAMMI: CAS Zone 4 · Medicine (2026 Xinrui edition); subscription journal; median 96 days to acceptance (43 articles, last 24 months); 47 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JAMMI is published by University of Toronto Press and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Use and Resistance, COVID-19 Clinical Research Studies and Antibiotic Resistance in Bacteria, together about 24.7% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Infectious Diseases
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Use and ResistanceImmunology and Microbiology12.7%
- COVID-19 Clinical Research StudiesMedicine6.3%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology5.7%
- SARS-CoV-2 and COVID-19 ResearchMedicine5%
- Infective Endocarditis Diagnosis and ManagementMedicine4.7%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology4.7%
- Respiratory viral infections researchMedicine4.3%
- Infection Control in HealthcareMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Infectious Diseases | Q3 | 253/361 | 30th |
| Microbiology (medical) | Q4 | 111/147 | 24th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.39LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 0.84OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 1.98%LetPub ·
Volume
- Articles per year
- 35LetPub ·
Articles by year OpenAlex count · 445 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 22 | 174 |
| 2025 | 47 | 41 | 270 |
| 2024 | 41 | 41 | 245 |
| 2023 | 40 | 40 | 212 |
| 2022 | 45 | 45 | 288 |
| 2021 | 53 | 49 | 388 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 71 days – 135 days
- Acceptance to online
- median 96 days (43 articles)
- Submission to online
- median 201 days
- Sample
- 43 articles with submission and acceptance dates (85 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- University of Toronto Press
- ISSN
- 2371-0888
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about JAMMI
What CAS zone is JAMMI in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at JAMMI?
Based on the dates recorded on 43 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 71–135 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index JAMMI?
According to LetPub and DOAJ records, JAMMI is indexed in ESCI and Scopus.
Is JAMMI open access, and what is the APC?
JAMMI is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .